---
$id: https://graph.org.ai/products/commodity/51181606
$type: Product
source: UNSPSC
code: "51181606"
title: "Propylthiouracil"
class: "51181600"
classTitle: "Thyroid and antithyroid drugs"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Propylthiouracil

**UNSPSC Code**: 51181606
**Class**: [Thyroid and antithyroid drugs](Thyroid and antithyroid drugs.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antithyroid agent with the molecular formula C7H10N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 721M9407IY, chemically known as 2,3-dihydro-6-propyl-2-thioxo-4(1h)-pyrimidinone but generally known as propylthiouracil, which bears US NIH Compound Identifier 657298. European Medicines Agency schedules Propylthiouracil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10123MIG. The term PROPYLTHIOURACIL is an International Non-Proprietary Name. World Health Organization schedules propylthiouracil in its Anatomical Therapeutic Chemical (ATC) Classification. PROPYLTHIOURACIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule propylthiouracil under HS 29335995 and SITC 51576. As of Q4 2014, PROPYLTHIOURACIL remains the US FDA Preferred Term for this commodity. Propylthiouracil bears US NLM identifiers UMLS ID C0033511 and NCI Concept Code C781. SMILES: S=C1[NH]C(CCC)CC(=O)[NH]1.

